Soluble plasma programmed death 1 (PD-1) and Tim-3 in primary HIV infection

被引:26
|
作者
Zilber, Eva [1 ]
Martin, Genevieve E. [1 ]
Willberg, Christian B. [1 ,2 ]
Fox, Julie [3 ,11 ]
Nwokolo, Nneka [4 ]
Fidler, Sarah [5 ,6 ,9 ]
Frater, John [1 ,2 ,7 ,10 ]
Lever, Andrew [8 ]
Wills, Mark [8 ]
Weber, Jonathan [9 ]
Fidler, Sarah [5 ,6 ,9 ]
Frater, John [1 ,2 ,7 ,10 ]
Dorrell, Lucy [10 ]
Malim, Mike [11 ]
Fox, Julie [3 ,11 ]
Gupta, Ravi [12 ]
Jolly, Clare [12 ]
机构
[1] Univ Oxford, Nuffield Dept Med, Oxford, England
[2] Natl Inst Hlth Res Biomed Res Ctr, Oxford, England
[3] Guys & St Thomas NHS Trust
[4] Chelsea & Westminster Hosp, London, England
[5] Imperial Coll, Wright Fleming Inst, Div Med, London, England
[6] Imperial Coll, Natl Inst Hlth Res, Biomed Res Ctr, London, England
[7] Oxford Martin Sch, Oxford, England
[8] Univ Cambridge, Cambridge, England
[9] Imperial Coll, London, England
[10] Univ Oxford, Oxford, England
[11] Kings Coll London, London, England
[12] UCL, London, England
关键词
T-CELLS; EXPRESSION;
D O I
10.1097/QAD.0000000000002165
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Soluble forms of the coinhibitory receptors programmed death 1 (PD-1) and Tim-3 exist, but their relationship with T-cell surface expression remains unclear. When measured by an enzyme-linked immunosorbent assay in plasma, soluble PD-1, and soluble Tim-3 were elevated during primary HIV infection, decreased on antiretroviral therapy to levels found in controls, and correlated with cell surface expression. We conclude that soluble PD-1 and soluble Tim-3 are easy to measure biomarkers of immune exhaustion which potentially eliminate the need for flow cytometry.
引用
收藏
页码:1253 / 1256
页数:4
相关论文
共 50 条
  • [21] Role of the Tim-3 and PD-1 pathways in T cell exhaustion and antitumor immunity
    Anderson, Ana C.
    CANCER RESEARCH, 2011, 71
  • [22] EXPRESSION AND CORRELATION OF PD-1 AND TIM-3 IN PATIENTS WITH ORAL SQUAMOUS CELL CARCINOMA
    Li, Liping
    Li, Lihong
    Lin, Wu
    ACTA MEDICA MEDITERRANEA, 2021, 37 (02): : 1069 - 1074
  • [23] Expression of the checkpoint receptors PD-1 and Tim-3 is increased in autoimmune blistering diseases
    Ernst, N.
    Schulz, A.
    Friedrich, M.
    Kasperkiewicz, M.
    Gross, N.
    Schmidt, E.
    Sadik, C. D.
    Zillikens, D.
    Hartmann, K.
    EXPERIMENTAL DERMATOLOGY, 2019, 28 (03) : E78 - E79
  • [24] Targeting PD-1, TIM-3 and LAG-3 in combination for improved immunotherapy combinations
    Kehry, Marilyn
    Horlick, Robert
    Bowers, Peter
    Jun, Toni
    Correia, Jean da Silva
    Graves, Jonathan
    Wang, Yan
    Laken, Haley
    King, David J.
    CANCER RESEARCH, 2015, 75
  • [25] Immune Checkpoint Profiling in Humanized Breast Cancer Mice Revealed Cell-Specific LAG-3/PD-1/TIM-3 Co-Expression and Elevated PD-1/TIM-3 Secretion
    Bruss, Christina
    Kellner, Kerstin
    Albert, Veruschka
    Hutchinson, James A.
    Seitz, Stephan
    Ortmann, Olaf
    Brockhoff, Gero
    Wege, Anja K.
    CANCERS, 2023, 15 (09)
  • [26] Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
    Riyao Yang
    Linlin Sun
    Ching-Fei Li
    Yu-Han Wang
    Jun Yao
    Hui Li
    Meisi Yan
    Wei-Chao Chang
    Jung-Mao Hsu
    Jong-Ho Cha
    Jennifer L. Hsu
    Cheng-Wei Chou
    Xian Sun
    Yalan Deng
    Chao-Kai Chou
    Dihua Yu
    Mien-Chie Hung
    Nature Communications, 12
  • [27] Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
    Yang, Riyao
    Sun, Linlin
    Li, Ching-Fei
    Wang, Yu-Han
    Yao, Jun
    Li, Hui
    Yan, Meisi
    Chang, Wei-Chao
    Hsu, Jung-Mao
    Cha, Jong-Ho
    Hsu, Jennifer L.
    Chou, Cheng-Wei
    Sun, Xian
    Deng, Yalan
    Chou, Chao-Kai
    Yu, Dihua
    Hung, Mien-Chie
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [28] Antibodies targeting BTLA or TIM-3 enhance HIV-1 specific T cell responses in combination with PD-1 blockade
    Grabmeier-Pfistershammer, Katharina
    Stecher, Carmen
    Zettl, Markus
    Rosskopf, Sandra
    Rieger, Armin
    Zlabinger, Gerhard J.
    Steinberger, Peter
    CLINICAL IMMUNOLOGY, 2017, 183 : 167 - 173
  • [29] GENERATION OF AZD7789, A NOVEL PD-1 AND TIM-3 TARGETING BISPECIFIC ANTIBODY, WHICH BINDS TO A DIFFERENTIATED EPITOPE OF TIM-3
    Clancy-Thompson, Eleanor
    Perry, Trinity
    Pryts, Stacy
    Jaiswal, Ashvin
    Oganesyan, Vaheh
    van Dyk, Nydia
    Yang, Chunning
    Garcia, Andrew
    Yu, Wenhan
    Moynihan, James
    Miller, Caroline
    Mulgrew, Kathy
    Cobbold, Mark
    Mazor, Yariv
    Hammond, Scott
    Pollizzi, Kristen
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A481 - A481
  • [30] Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis
    Atesoglu, Elif Birtas
    Tarkun, Pinar
    Demirsoy, Esra Terzi
    Geduk, Ayfer
    Mehtap, Ozgur
    Batman, Adnan
    Kaya, Fatih
    Cekmen, Mustafa Baki
    Gulbas, Zafer
    Hacihanefioglu, Abdullah
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2016, 22 (03) : 248 - 251